Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure

Fig. 3

Effect of IL-8 on hUC-MSCs therapy for ALF. AThe inhibitory effect of siRNA on IL-8 expression in hUC-MSCs. B Survival curves of different hUC-MSCs treatment groups (n = 15). C Serum ALT and AST levels of rats in different treatment groups (n = 5 ~ 10). D HE staining was used to observe the pathological changes in liver tissue. Scale bar = 50 μm.*P < 0.05; **P < 0.01; ***P < 0.001(DPI:300)

Back to article page